用于疾病治疗的CXCR4抗体的开发和治疗前景
Jun Yang1, Erkang Tian2, Li Chen1
1Department of Neurology, Laboratory of Neuro-system and Multimorbidity and State Key Laboratory of Biotherapy and Cancer Center and Institute of Respiratory Health and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
化学因子受体4 (CXCR4) 抗剂是癌症和艾滋病毒等疾病的有希望的药物标. 本综述详细介绍了它们的结构-活性关系以及改善药物开发的潜力.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 化基因受体4 (CXCR4),GPCR家族成员,与HIV-1感染,癌症和炎症有关.
- 它在各种疾病中的参与使得CXCR4成为治疗干预的重要目标.
- 目前的CXCR4抗剂临床试验主要利用和抗体,有限的小分子探索.
研究的目的:
- 审查CXCR4抗剂的结构活性关系 (SAR).
- 探索CXCR4在疾病发病过程中的作用及其结合相互作用.
- 提出提高CXCR4向药物的疗效的策略.
主要方法:
- 文献综述侧重于CXCR4结构-活动关系.
- 分析现有的CXCR4抗剂,包括小分子,和抗体.
- 探索特定疾病的CXCR4结合特征和修改策略.
主要成果:
- 详细讨论各种CXCR4抗剂的SAR.
- 识别共同的结构特征和目标相互作用.
- 修改方法的概述,以优化药物的有效性.
结论:
- CXCR4对抗剂在多种疾病领域具有显著的治疗潜力.
- 了解SAR对于设计有效的CXCR4向药物至关重要.
- 对修改策略的进一步研究可能会导致改进的候选药物.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotaxis and Direction of Cell Migration
